Physician profile
Christopher Heath Fine
NPI 1134515950
$1,589.31
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $613 · 2020: $359 · 2021: $374 · 2022: $203 · 2024: $40.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $40.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $40.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $450.53 | 2019-2024 | Perclose Prostyle |
| Abiomed | $295.73 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $274.30 | 2019-2021 | |
| Boston Scientific Corporation | $262.78 | 2020-2022 | |
| Medtronic Vascular, INC. | $91.36 | 2019-2020 | |
| Cardinal Health 200 LLC | $64.93 | 2019 | |
| Lantheus Medical Imaging, INC. | $59.75 | 2019 | |
| Impulse Dynamics (USA) INC. | $27.78 | 2022 | |
| Amgen INC. | $18.37 | 2021 | |
| Celgene Corporation | $16.92 | 2024 | Reblozyl |
| Ge Healthcare | $12.31 | 2021 | |
| Zoll Circulation INC | $9.13 | 2019 | |
| Cardiovascular Systems INC. | $5.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Fine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.